Bei Akademie registrieren
Eli Lilly and Co., US5324571083

Eli Lilly stock at EUR 1,278, up 0.31% premarket

Published on 11/05/2026 at 08:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eli Lilly develops and commercializes human medicines worldwide. The reference base is the Xetra close of November 4, 2026 at EUR 1,274.

Business and market setup

  • Eli Lilly researches, develops and commercializes human medicines worldwide.
  • The company operates across diabetes, oncology, autoimmune and neurological treatments.
Eli Lilly and Co., US5324571083, Illustration mit AI erstellt.
Eli Lilly and Co., US5324571083, Illustration mit AI erstellt.

The real-time quote of Eli Lilly stock traded at EUR 1,278 on Lang & Schwarz at 08:19 CET on Thursday, November 5, 2026, 0.31 percent above the Xetra close of Wednesday, November 4, at EUR 1,274.

Eli Lilly and Company is a global pharmaceutical business focused on the research, development and commercialization of human medicines. Its portfolio spans diabetes care, oncology, autoimmune diseases and neurological conditions, giving investors several therapeutic areas to monitor alongside the share price.

The S&P 500 provides the broader market backdrop for US-listed Eli Lilly stock ahead of the opening bell.

More news and analyses on Eli Lilly stock.

Disclaimer...
en | US5324571083 | ELI LILLY AND CO. | boerse | 70461679 |